Andera Partners | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Home
Companies
Andera Partners

BRIEF

published on 11/13/2024 at 13:05, 7 days 21 hours ago

Andera Partners Expands Internationally with New Madrid Office

Private Equity International Expansion Andera Partners Madrid Office Spanish Market
PRESS RELEASE

published on 11/13/2024 at 13:00, 7 days 21 hours ago

ANDERA PARTNERS CONTINUES ITS INTERNATIONAL EXPANSION AND ANNOUNCES THE OPENING OF A MADRID OFFICE
Andera Partners announces opening of Madrid office for private equity strategy in Spain led by Gonzalo Boada, continuing international expansion

Private Equity International Expansion Andera Partners Madrid Office Gonzalo Boada
BRIEF

published on 07/26/2024 at 09:05, 3 months 26 days ago

Andera Partners Co-Leads $196 Million Round for Kestra Medical

Medical Devices Financing Andera Partners Wearable Defibrillator Raymond W. Cohen
PRESS RELEASE

published on 07/26/2024 at 09:00, 3 months 26 days ago

Andera Partners Co-Leads $196 Million Round for Kestra Medical and Welcomes Raymond W. Cohen to Board of Directors
Andera Partners co-leads $196 million financing round for Kestra Medical, appoints Raymond W. Cohen to the board. Kestra develops a wearable defibrillator vest for cardiac patients

Financing Andera Partners Wearable Defibrillator Raymond W. Cohen Kestra Medical
BRIEF

published on 07/25/2024 at 10:05, 3 months 27 days ago

Andera Partners’ Portfolio Company JenaValve Technology Acquired by Edwards Lifesciences

Acquisition Private Equity FDA Approval Cardiovascular Innovations Heart Valve Technology
PRESS RELEASE

published on 07/25/2024 at 10:00, 3 months 27 days ago

Andera Partners’ portfolio company JenaValve Technology acquired by Edwards Lifesciences
Andera Partners' portfolio company JenaValve Technology acquired by Edwards Lifesciences, marking a significant milestone in cardiovascular innovation with FDA approval expected by late 2025

Acquisition Andera Partners Edwards Lifesciences JenaValve Technology Cardiovascular Innovation
BRIEF

published on 07/25/2024 at 09:35, 3 months 27 days ago

TRiCares Secures $50 Million Series D Financing for Clinical Advancements

Clinical Trials Andera Partners TRiCares Series D Financing Heart Valve System
PRESS RELEASE

published on 07/25/2024 at 09:30, 3 months 27 days ago

Andera Partners’ portfolio company TRiCares secures $50 million in Series D Financing to Support Upcoming Clinical Milestones
Andera Partners' portfolio company TRiCares secures $50 million in Series D Financing to support upcoming clinical milestones for its tricuspid heart valve replacement system, Topaz

Clinical Milestones Andera Partners TRiCares Series D Financing Topaz
BRIEF

published on 07/15/2024 at 09:35, 4 months 6 days ago

Amolyt Pharma, a Portfolio Company of Andera Partners, Acquired by AstraZeneca

Acquisition Biopharmaceuticals AstraZeneca Amolyt Pharma Rare Diseases
PRESS RELEASE

published on 07/15/2024 at 09:30, 4 months 6 days ago

Andera Partners’ portfolio company Amolyt Pharma completes acquisition by AstraZeneca
Andera Partners' portfolio company Amolyt Pharma has been acquired by AstraZeneca for $1.05 billion, enhancing AstraZeneca's Rare Disease late-stage pipeline and bone metabolism franchise

Acquisition Biopharmaceutical AstraZeneca Amolyt Pharma Andera Partners

Accesswire

Published on 11/21/2024 at 10:03, 34 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 37 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 37 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 2 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 12 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 32 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 35 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 37 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 37 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 36 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 39 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 17 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 52 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 52 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE